Latest filing published 29 Jun 2016 for Cartesian Therapeutics, Inc..
Insider track record
No signal scores available.
VTB Capital I2BF Netherlands, B.V.: trading record in brief
All filings by VTB Capital I2BF Netherlands, B.V. on record concern Cartesian Therapeutics, Inc. Activity is concentrated on a single trading day, 27 June 2016, with 2 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 29 June 2016, reports a transaction in Cartesian Therapeutics, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to VTB Capital I2BF Netherlands, B.V.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 178,890 shares0Common StockSEC:0001104659-16-130149:0
- 178,890 shares0Common StockSEC:0001104659-16-130149:1
2 of 2 declarations
